<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Airway management in the patient with elevated ICP for emergency medicine and critical care</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Airway management in the patient with elevated ICP for emergency medicine and critical care</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Airway management in the patient with elevated ICP for emergency medicine and critical care</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Andy Jagoda, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Cappi Lay, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ron M Walls, MD, FRCPC, FAAEM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Ganetsky, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Sep 19, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Patients with acute elevations in intracranial pressure (ICP) from trauma, stroke, infection of the central nervous system, or other processes often require emergency airway management. In managing these patients, certain medications and techniques reduce the likelihood of major fluctuations in cerebral perfusion pressure, which can exacerbate brain injury.</p><p>This topic will discuss emergency airway management in patients with elevated ICP outside the operating room. Other aspects of emergency airway management and diseases that cause elevations in ICP are reviewed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>For further discussion of emergency airway management: (see  <a class="medical medical_review" href="/z/d/html/267.html" rel="external">"Basic airway management in adults"</a> and  <a class="medical medical_review" href="/z/d/html/276.html" rel="external">"Overview of advanced airway management in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a>).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For discussions of injuries and diseases that elevate ICP: (see  <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults"</a> and  <a class="medical medical_review" href="/z/d/html/344.html" rel="external">"Skull fractures in adults"</a> and  <a class="medical medical_review" href="/z/d/html/4826.html" rel="external">"Management of acute moderate and severe traumatic brain injury"</a> and  <a class="medical medical_review" href="/z/d/html/1083.html" rel="external">"Overview of the evaluation of stroke"</a> and  <a class="medical medical_review" href="/z/d/html/5182.html" rel="external">"Management of vasogenic edema in patients with primary and metastatic brain tumors"</a> and  <a class="medical medical_review" href="/z/d/html/6566.html" rel="external">"Severe traumatic brain injury (TBI) in children: Initial evaluation and management"</a>).</p><p></p><p class="headingAnchor" id="H2"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Cerebral perfusion pressure (CPP) is the driving force for blood flow to the brain. It is calculated by taking the difference between the mean arterial blood pressure (MAP) and the intracranial pressure (ICP), as expressed in the formula CPP = MAP – ICP. The pathophysiology of elevated ICP is discussed in detail separately; issues of particular relevance to airway management are highlighted below. (See  <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults"</a> and  <a class="medical medical_review" href="/z/d/html/6077.html" rel="external">"Elevated intracranial pressure (ICP) in children: Clinical manifestations and diagnosis"</a>.)</p><p>Autoregulation is the ability to regulate cerebral blood flow (CBF) over a wide range of MAPs. CPP is typically preserved through a MAP range of approximately 60 to 160 mmHg. When severe intracranial hypertension develops, autoregulation often is impaired. In this setting, excessive systemic hypotension can aggravate brain injury by causing cerebral hypoperfusion and hypoxemia, with resultant cerebral edema and increasing ICP. Hypotension is especially harmful and must be anticipated and avoided whenever possible. Mild permissive systemic hypertension might be necessary in the setting of increased ICP to maintain cerebral perfusion. Excessive hypertension, especially in the setting of impaired autoregulation, can further increase ICP.</p><p>Patients with intracranial hypertension present a particular clinical challenge, since many airway management techniques potentially increase ICP. Often, these patients are the victims of multiple trauma and present with hypovolemia with or without hypotension, thus limiting the choice of agents and techniques available.</p><p>In such cases, it might appear that increases in MAP would be beneficial by allowing CPP and oxygenation of brain tissue to be maintained. However, because of the loss of autoregulation in patients with intracranial injury, increases in MAP can translate directly into increases in ICP. Thus, not only is the driving gradient for CPP increased, but the absolute ICP is increased as well. Accordingly, it is important to try to maintain the MAP in a reasonable range (approximately 100 to 110 mmHg) to optimize cerebral perfusion and to minimize absolute ICP.</p><p>The techniques and medications used in airway management may increase ICP through several mechanisms. These include the reflex sympathetic response to laryngoscopy (RSRL), other reflexive responses to stimulation and manipulation of the upper airway (eg, laryngoscopy and placement of the endotracheal tube), and the direct increase in ICP stimulated by certain medications used during intubation [<a href="#rid1">1,2</a>]. Likewise, medications used in rapid sequence intubation (RSI) may cause sympatholysis with consequent hypotension; thus, having <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> available at the bedside may be helpful.</p><p>The RSRL is stimulated by the sensory innervation of the supraglottic larynx, which results in increased serum levels of <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>, <a class="drug drug_general" data-topicid="9709" href="/z/d/drug information/9709.html" rel="external">norepinephrine</a>, and vasopressin [<a href="#rid3">3-5</a>]. The innervation of the upper and lower airways is discussed in detail separately. (See  <a class="medical medical_review" href="/z/d/html/529.html" rel="external">"Neuronal control of the airways"</a>.)</p><p>Use of the laryngoscope or attempted placement of an endotracheal tube results in a significant afferent discharge that increases cardiovascular sympathetic activity. For direct laryngoscopy attempts up to 45 seconds in duration, the longer the attempt the greater the sympathetic nervous system stimulation [<a href="#rid6">6</a>]. Both the lighted stylet and fiberoptic techniques result in reflex sympathetic responses that are comparable to direct laryngoscopy [<a href="#rid4">4,7-9</a>].</p><p>The catecholamine surge caused by RSRL leads to an increased heart rate and blood pressure, which significantly enhances cerebral blood flow (CBF) through redistribution and increased cerebral blood volume [<a href="#rid10">10,11</a>]. Ultimately, these hemodynamic changes can exacerbate intracranial hypertension if autoregulation is impaired, and therefore, it is desirable to mitigate such responses.</p><p class="headingAnchor" id="H3"><span class="h1">RAPID SEQUENCE INTUBATION FOR ELEVATED ICP</span><span class="headingEndMark"> — </span>We believe rapid sequence intubation (RSI) is the preferred method for securing the airway in patients with suspected elevated intracranial pressure (ICP). This recommendation is based upon its high success rate and low incidence of complications. However, no outcome studies have been performed to determine the best approach to airway management in these patients.</p><p>RSI protocols are designed to minimize potentially adverse reactions, such as the reflex sympathetic response that occurs during airway manipulation. Assessment of the airway and the performance of RSI are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/275.html" rel="external">"Approach to the difficult airway in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a>.)</p><p>When performing RSI in the patient with elevated ICP, gentle, controlled technique is desired and prolonged or multiple attempts at intubation should be avoided whenever possible. Minimizing stimulation of the supraglottic larynx reduces the reflexive responses that can exacerbate elevations in ICP. (See <a class="local">'Pathophysiology'</a> above.)</p><p>The use of RSI in patients with the potential for neurologic deficits carries the responsibility of performing and documenting an appropriate neurologic evaluation, when possible, prior to the initiation of neuromuscular blockade. The assessment should include the patient's ability to interact with surroundings, pupillary reflexes, and motor response to voice and pain. The careful recording of these findings establishes a baseline for comparison during subsequent monitoring, as well as providing important prognostic information.</p><p>Maintaining oxygenation is vital in patients with elevated ICP. Preoxygenation plays an important role in RSI by allowing the clinician to maintain high oxyhemoglobin saturation without requiring bag-mask ventilation while neuromuscular blockade takes effect, thereby minimizing the risk of aspiration. However, if the patient's oxygenation is compromised, positive pressure ventilation with a bag and mask may be required throughout the pre-intubation sequence. In such circumstances, the increased risk of aspiration is offset by the hazard of inadequate oxygenation. (See  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care", section on 'Preoxygenation'</a>.)</p><p>Do not forego appropriate induction and neuromuscular blocking agents in the comatose patient who is to undergo RSI. The pathologic reflexes described above do occur in comatose patients, though they may appear unresponsive [<a href="#rid12">12</a>].</p><p class="headingAnchor" id="H4"><span class="h1">PRETREATMENT AGENTS FOR RSI</span></p><p class="headingAnchor" id="H5"><span class="h2">Overview and approach</span><span class="headingEndMark"> — </span>Intracranial pressure (ICP) can increase as a result of the reflex sympathetic response to laryngoscopy (RSRL) and direct reflexive responses to airway manipulation. The mechanisms by which these responses occur are outlined above. (See <a class="local">'Pathophysiology'</a> above.)</p><p>In a patient whose condition would be exacerbated by a rise in ICP, when time allows, we suggest pretreatment with a short-acting opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) to blunt the rise in ICP caused by the adverse responses during rapid sequence intubation (RSI) discussed above. Such conditions may include acute brain injury, ischemic stroke, intracranial hemorrhage, meningitis or encephalitis, cerebral edema, and hypertensive encephalopathy  (<a class="graphic graphic_table graphicRef69683" href="/z/d/graphic/69683.html" rel="external">table 1</a>). (See  <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults"</a>.)</p><p>We give <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> 3 mcg/kg intravenously (IV) over 30 to 60 seconds. Fentanyl should <strong>not</strong> be given to hypotensive patients or patients with hypovolemia who are dependent upon sympathetic drive to maintain a minimally compensated blood pressure.</p><p>No outcome studies have demonstrated that transient increases in ICP result in worse patient outcomes, and the use of pretreatment medications should be viewed as supplementary (ie, nonessential) in RSI. Nevertheless, short-acting opioids are relatively safe and may be beneficial when given in the proper setting. (See <a class="local">'Ultra-short acting opioid'</a> below.)</p><p>The findings of studies of the effects of <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> on elevated ICP are inconsistent and we no longer suggest pretreatment with lidocaine. While short-acting beta blockers (ie, <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">esmolol</a>) minimize reflex hypertension and tachycardia due to laryngoscopy, they are not used in the acute trauma setting because of the risk of hypotension. The use of a defasciculating dose of a nondepolarizing neuromuscular blocking agent to reduce the ICP response that occurs during the fasciculations caused by <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> is of unproven benefit and is not recommended. (See <a class="local">'Lidocaine'</a> below and <a class="local">'Beta blocker'</a> below and <a class="local">'Defasciculating dose of NMBA'</a> below.)</p><p class="headingAnchor" id="H7"><span class="h2">Ultra-short acting opioid</span><span class="headingEndMark"> — </span>A single pretreatment dose of an ultra-short acting opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>, <a class="drug drug_general" data-topicid="9347" href="/z/d/drug information/9347.html" rel="external">alfentanil</a>, <a class="drug drug_general" data-topicid="9954" href="/z/d/drug information/9954.html" rel="external">sufentanil</a>) given over 30 to 60 seconds mitigates the RSRL without causing hypoventilation or respiratory depression.</p><p>Multiple small randomized trials have demonstrated the effectiveness of <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a> in this regard when given at a dose of 5 mcg/kg IV [<a href="#rid13">13-15</a>]. However, this dose may cause premature respiratory depression during RSI. Some observational trials found that fentanyl, at a dose of 2 to 3 mcg/kg IV, mitigates the RSRL [<a href="#rid16">16</a>], but other studies found no benefit unless <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">esmolol</a> was given concurrently [<a href="#rid17">17-19</a>]. Administering a reduced dose of fentanyl (3 mcg/kg) seems to provide the best balance between the desired (sympathetic blockade) and undesired (respiratory depression) effects.</p><p><a class="drug drug_general" data-topicid="9347" href="/z/d/drug information/9347.html" rel="external">Alfentanil</a> showed superior hemodynamic attenuation of RSRL in one study, but is relatively unknown to emergency physicians and not used for other purposes in emergency practice [<a href="#rid20">20</a>].</p><p class="headingAnchor" id="H75316048"><span class="h2">Lidocaine</span><span class="headingEndMark"> — </span>There is no high quality evidence that directly addresses whether pretreatment with <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> effectively reduces the rise in ICP caused by laryngoscopy and endotracheal intubation (ETI) [<a href="#rid21">21,22</a>]. In small, randomized and nonrandomized clinical trials, IV lidocaine has shown mixed and inconsistent attenuation of the blood pressure and pulse response to ETI [<a href="#rid11">11,16,23-25</a>]. Studies of the drug's effect upon ICP also report inconsistent results. Several small randomized trials have found that lidocaine minimizes the rise in ICP in patients undergoing neurosurgical procedures [<a href="#rid26">26</a>] or endotracheal suctioning [<a href="#rid27">27-29</a>]. In contrast, other randomized trials have found no benefit from pretreatment with lidocaine in blunting ICP rise during ETI [<a href="#rid30">30</a>] or endotracheal suctioning [<a href="#rid31">31</a>].</p><p>Given these conflicting studies, we believe there is insufficient evidence to recommend that <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> be used as a pretreatment agent for patients with elevated ICP undergoing RSI.</p><p class="headingAnchor" id="H8"><span class="h2">Beta blocker</span><span class="headingEndMark"> — </span>In multiple small randomized trials, the short-acting beta blocker <a class="drug drug_general" data-topicid="9420" href="/z/d/drug information/9420.html" rel="external">esmolol</a>, given at a dose of 2 mg/kg IV, has demonstrated the ability to control both heart rate and blood pressure responses to intubation [<a href="#rid17">17,32-34</a>]. Unfortunately, esmolol may cause hypotension, which must be avoided at all costs in the head-injured patient. For this reason, although esmolol is consistent and reliable for mitigation of RSRL in elective anesthesia, it is generally <strong>not</strong> used for this purpose in the emergency department.</p><p class="headingAnchor" id="H9"><span class="h2">Defasciculating dose of NMBA</span><span class="headingEndMark"> — </span>There is no high quality evidence to support the use of a small (ie, defasciculating) dose of a nondepolarizing neuromuscular blocking agent (NMBA) to blunt the potential rise in ICP caused by the fasciculations that accompany <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> (SCh) administration [<a href="#rid35">35</a>]. This practice adds complexity to airway management without clear benefit and we do not suggest such treatment.</p><p class="headingAnchor" id="H10"><span class="h1">CHOICE OF INDUCTION AGENT FOR RSI</span><span class="headingEndMark"> — </span>We suggest that <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">etomidate</a> (0.3 mg/kg intravenous [IV] push) be used as the induction agent for rapid sequence intubation (RSI) in patients with elevated ICP, particularly those who are hypotensive or at risk for hypotension. <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">Ketamine</a> (1 to 2 mg/kg IV) can also be used as the induction agent in normotensive or hypotensive patients. For patients with elevated ICP who are at no risk of hypotension, sodium thiopental may be used. Induction agents for RSI are discussed in detail separately; some aspects relevant to their use in patients with elevated ICP are described here. (See  <a class="medical medical_review" href="/z/d/html/271.html" rel="external">"Induction agents for rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p><a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">Etomidate</a> is a short-acting imidazole derivative with rapid onset, stable hemodynamics, and minimal impact on respiratory drive. Etomidate has a safe hemodynamic profile, even when used in patients who are hypovolemic or cardiovascularly impaired. It has been shown to decrease the basal metabolic rate of oxygen utilization of the brain (CMRO2) and ICP in a fashion similar to thiopental [<a href="#rid36">36,37</a>].</p><p><a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">Ketamine</a> is a dissociative anesthetic with analgesic and amnestic properties. Among its many effects, ketamine stimulates catecholamine receptors leading to increases in mean arterial blood pressure and cerebral blood flow. Thus, we believe ketamine is an appropriate induction agent for normotensive or hypotensive patients with elevated ICP. However, the use of ketamine in head-injured patients remains controversial among some clinicians; this issue is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/271.html" rel="external">"Induction agents for rapid sequence intubation in adults for emergency medicine and critical care", section on 'Ketamine'</a>.)</p><p><a class="drug drug_general" data-topicid="9629" href="/z/d/drug information/9629.html" rel="external">Methohexital</a> is a short-acting barbiturate that provides a cerebroprotective effect by decreasing CMRO2. In addition, methohexital decreases cerebral blood flow, thus decreasing ICP. This ability to decrease both ICP and CMRO2 makes methohexital attractive. However, methohexital is a negative inotrope and vasodilator that can ultimately reduce mean arterial blood pressure and CPP [<a href="#rid38">38</a>]. Consequently, methohexital should only be used in patients with stable hemodynamics, and even then should be used with caution. </p><p class="headingAnchor" id="H11"><span class="h1">CHOICE OF NEUROMUSCULAR BLOCKING AGENT FOR RSI</span><span class="headingEndMark"> — </span>We suggest that <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> (SCh; 1.5 mg/kg intravenously [IV]) be used as the neuromuscular blocking agent (NMBA) for rapid sequence intubation (RSI) in patients with elevated ICP because of its rapid onset, consistent and reliable effects, and short duration of action [<a href="#rid39">39</a>]. NMBAs for RSI are discussed in detail separately; their use in patients with elevated ICP is described here. (See  <a class="medical medical_review" href="/z/d/html/279.html" rel="external">"Neuromuscular blocking agents (NMBAs) for rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p>In animal studies, SCh causes a temporary increase in intracranial pressure (ICP) during the fasciculation phase [<a href="#rid40">40,41</a>]. However, one small observational study in humans showed no such effect [<a href="#rid42">42</a>], and the clinical significance of this phenomenon remains unknown.</p><p>The administration of a small "defasciculating" dose of a nondepolarizing NMBA or a mini-dose (20 mg) of <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> has been used to reduce fasciculations, but the effect of these practices upon ICP remains unclear and this approach is no longer recommended. (See <a class="local">'Defasciculating dose of NMBA'</a> above.)</p><p>Contraindications to the use of SCh include the following: </p><p class="bulletIndent1"><span class="glyph">●</span>Malignant hyperthermia history (personal or family) </p><p class="bulletIndent1"><span class="glyph">●</span>Neuromuscular disease involving denervation (note SCh is safe in myasthenia gravis) </p><p class="bulletIndent1"><span class="glyph">●</span>Muscular dystrophy</p><p class="bulletIndent1"><span class="glyph">●</span>Stroke over 72 hours old</p><p class="bulletIndent1"><span class="glyph">●</span>Rhabdomyolysis</p><p class="bulletIndent1"><span class="glyph">●</span>Burn over 72 hours old</p><p class="bulletIndent1"><span class="glyph">●</span>Significant hyperkalemia (eg, suggested by characteristic changes on an electrocardiogram) </p><p></p><p>Nondepolarizing (ie, competitive) NMBAs do not cause an elevation of ICP. <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">Rocuronium</a> is the most commonly available short-acting competitive agent. However, although rocuronium is relatively short-acting, spontaneous respiration does not return for up to 45 minutes after its use if a reversal agent (ie, <a class="drug drug_general" data-topicid="105866" href="/z/d/drug information/105866.html" rel="external">sugammadex</a>) is not given. Studies have not demonstrated an outcome benefit to the use of a nondepolarizing versus a depolarizing NMBA. Some clinicians use "double-dose" rocuronium to mimic the effects of <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> without its potential downsides, but this approach can delay performing an accurate neurologic examination for up to two hours, and this risk must be carefully weighed against any potential benefit.</p><p class="headingAnchor" id="H12"><span class="h1">AWAKE INTUBATION</span><span class="headingEndMark"> — </span>Rarely, an "awake" approach to intubation may be preferable when a difficult airway is predicted in patients with elevated ICP. Awake intubation is discussed further separately. (See  <a class="medical medical_review" href="/z/d/html/271.html" rel="external">"Induction agents for rapid sequence intubation in adults for emergency medicine and critical care", section on 'Conditions precluding use of a paralytic'</a>.)</p><p>The risks and benefits of awake intubation must be weighed carefully in this setting due to the risk of further elevations in ICP from the stimulatory effects of intubation. The most gentle intubation technique possible, usually flexible fiberoptic intubation, should be used.</p><p>Although patients with elevated ICP have a decreased level of consciousness, the use of topical anesthesia, intravenous (IV) sedation, and IV opioid analgesia is advisable. When time permits, a drying agent (eg, <a class="drug drug_general" data-topicid="8496" href="/z/d/drug information/8496.html" rel="external">glycopyrrolate</a> 0.2 to 0.4 mg IV) improves the efficacy of topical anesthetics and should be used. Topical anesthesia, such as <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">lidocaine</a> 4%, can be combined with a vasoconstrictor, such as topical <a class="drug drug_general" data-topicid="9768" href="/z/d/drug information/9768.html" rel="external">phenylephrine</a> 0.5%, and administered via nebulizer [<a href="#rid43">43</a>]. The choices of sedative agent and opioid analgesic are the same as for the patient with normal intracranial pressure and are guided by assessment of the patient's hemodynamic and respiratory status.</p><p class="headingAnchor" id="H13"><span class="h1">INITIATING MECHANICAL VENTILATION</span><span class="headingEndMark"> — </span>Mechanical ventilation in the patient with elevated intracranial pressure (ICP) should be predicated upon three principles:</p><p class="bulletIndent1"><span class="glyph">●</span>Optimize oxygenation</p><p class="bulletIndent1"><span class="glyph">●</span>Prevent hypocapnia</p><p class="bulletIndent1"><span class="glyph">●</span>Avoid ventilation mechanics that increase cerebral venous congestion (eg, positive end-expiratory pressure, high peak inspiratory pressure)</p><p></p><p>Reduction in PaCO<sub>2</sub> tensions in the brain leads to vasoconstriction, decreased cerebral blood flow, and decreased ICP. Therefore, patients should be ventilated in such a way as to target the lower limits of normocapnia (PaCO<sub>2</sub> of 35 mmHg). Hypocapnia (PaCO<sub>2</sub> &lt;35) is linked to worse patient outcomes in both prehospital [<a href="#rid44">44</a>] and in-hospital studies [<a href="#rid45">45</a>]. Consequently, carbon dioxide tension should be followed with continuous capnography and correlated with arterial blood gas analysis. Hyperventilation to a PaCO<sub>2</sub> of 30 mmHg should only be used when osmotic agents and CSF drainage are not effective in managing an acute rise in ICP that is accompanied by neurologic deterioration. </p><p>Long-term analgesia and sedation should be used as needed to permit effective mechanical ventilation, minimize sympathetic response, and reduce elevated ICP. Postintubation sedation is best accomplished with <a class="drug drug_general" data-topicid="9826" href="/z/d/drug information/9826.html" rel="external">propofol</a> or <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">midazolam</a>, which reduce the cerebral metabolic rate of oxygen (CMRO<sub>2</sub>) and contribute to lowering ICP. Opioids do not lower the CMRO<sub>2</sub> and have an unpredictable effect on ICP, and thus we recommend that they be avoided if possible. If these measures are ineffective, pharmacological paralysis may be needed. Further discussion of mechanical ventilation and monitoring in the setting of elevated ICP is found separately. (See  <a class="medical medical_review" href="/z/d/html/277.html" rel="external">"Mechanical ventilation of adults in the emergency department", section on 'Elevated intracranial pressure'</a> and  <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">"Evaluation and management of elevated intracranial pressure in adults"</a> and  <a class="medical medical_review" href="/z/d/html/277.html" rel="external">"Mechanical ventilation of adults in the emergency department", section on 'General IPPV'</a>.)</p><p class="headingAnchor" id="H3924049166"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/127884.html" rel="external">"Society guideline links: Airway management in adults"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Airway management and increased intracranial pressure (ICP)</strong> – The techniques and medications used in airway management may increase ICP through several mechanisms. Such elevations can cause harm in patients whose ICP is already high due to acute brain injury, ischemic stroke, intracranial hemorrhage, meningitis or encephalitis, cerebral edema, and hypertensive encephalopathy. (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rapid sequence intubation (RSI)</strong> – RSI is the primary method for securing the airway in patients with suspected elevated ICP whose airways are not anticipated to be difficult. Assessment of the airway and the performance of RSI are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/275.html" rel="external">"Approach to the difficult airway in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/270.html" rel="external">"Rapid sequence intubation in adults for emergency medicine and critical care"</a> and  <a class="medical medical_review" href="/z/d/html/6390.html" rel="external">"Rapid sequence intubation (RSI) in children for emergency medicine: Approach"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pretreatment with </strong><strong>fentanyl</strong> – Pretreatment medications are optional when performing RSI. When time allows, we suggest pretreatment with a short-acting opioid (eg, <a class="drug drug_general" data-topicid="8441" href="/z/d/drug information/8441.html" rel="external">fentanyl</a>) to blunt the rise in ICP during RSI in patients whose condition would be exacerbated by any further increase (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). We give fentanyl 3 mcg/kg intravenously [IV] over 30 to 60 seconds. Fentanyl should <strong>not</strong> be given to hypotensive patients or patients with hypovolemia who are dependent upon sympathetic drive to maintain blood pressure. (See <a class="local">'Overview and approach'</a> above and <a class="local">'Lidocaine'</a> above and <a class="local">'Ultra-short acting opioid'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Induction agent for RSI</strong> – We suggest that <a class="drug drug_general" data-topicid="8428" href="/z/d/drug information/8428.html" rel="external">etomidate</a> (0.3 mg/kg IV push) be used as the induction agent for RSI in patients with elevated ICP (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). <a class="drug drug_general" data-topicid="8588" href="/z/d/drug information/8588.html" rel="external">Ketamine</a> (1 to 2 mg/kg IV) may be used in hypotensive or normotensive patients. For patients with elevated ICP who are at no risk of hypotension, <a class="drug drug_general" data-topicid="9629" href="/z/d/drug information/9629.html" rel="external">methohexital</a> may be used. (See  <a class="medical medical_review" href="/z/d/html/271.html" rel="external">"Induction agents for rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neuromuscular blocking agent for RSI</strong> – We suggest that <a class="drug drug_general" data-topicid="9952" href="/z/d/drug information/9952.html" rel="external">succinylcholine</a> (1.5 mg/kg IV) be used as the neuromuscular blocking agent (NMBA) for RSI in patients with elevated ICP (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). We prefer succinylcholine because of its rapid onset, consistent and reliable effects, and short duration of action. Contraindications to succinylcholine are listed in the text. Nondepolarizing (ie, competitive) NMBAs such as <a class="drug drug_general" data-topicid="9872" href="/z/d/drug information/9872.html" rel="external">rocuronium</a> do not cause an elevation of ICP and can also be used for RSI in this setting. (See <a class="local">'Choice of neuromuscular blocking agent for RSI'</a> above and  <a class="medical medical_review" href="/z/d/html/279.html" rel="external">"Neuromuscular blocking agents (NMBAs) for rapid sequence intubation in adults for emergency medicine and critical care"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Post-intubation monitoring</strong> – We suggest that all patients with elevated ICP who are intubated be monitored using continuous capnography in order to avoid inadvertent hypocapnia (pCO<sub>2</sub> &lt;35). (See <a class="local">'Initiating mechanical ventilation'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Perkins ZB, Wittenberg MD, Nevin D, et al. The relationship between head injury severity and hemodynamic response to tracheal intubation. J Trauma Acute Care Surg 2013; 74:1074.</a></li><li><a class="nounderline abstract_t">Muller MD, Mast JL, Cui J, et al. Tactile stimulation of the oropharynx elicits sympathoexcitation in conscious humans. J Appl Physiol (1985) 2013; 115:71.</a></li><li><a class="nounderline abstract_t">Kayhan Z, Aldemir D, Mutlu H, Oğüş E. Which is responsible for the haemodynamic response due to laryngoscopy and endotracheal intubation? Catecholamines, vasopressin or angiotensin? Eur J Anaesthesiol 2005; 22:780.</a></li><li><a class="nounderline abstract_t">Takahashi S, Mizutani T, Miyabe M, Toyooka H. Hemodynamic responses to tracheal intubation with laryngoscope versus lightwand intubating device (Trachlight) in adults with normal airway. Anesth Analg 2002; 95:480.</a></li><li><a class="nounderline abstract_t">Shribman AJ, Smith G, Achola KJ. Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation. Br J Anaesth 1987; 59:295.</a></li><li><a class="nounderline abstract_t">Stoelting RK. Circulatory changes during direct laryngoscopy and tracheal intubation: influence of duration of laryngoscopy with or without prior lidocaine. Anesthesiology 1977; 47:381.</a></li><li><a class="nounderline abstract_t">Tewari P, Gupta D, Kumar A, Singh U. Opioid sparing during endotracheal intubation using McCoy laryngoscope in neurosurgical patients: the comparison of haemodynamic changes with Macintosh blade in a randomized trial. J Postgrad Med 2005; 51:260.</a></li><li><a class="nounderline abstract_t">Barak M, Ziser A, Greenberg A, et al. Hemodynamic and catecholamine response to tracheal intubation: direct laryngoscopy compared with fiberoptic intubation. J Clin Anesth 2003; 15:132.</a></li><li><a class="nounderline abstract_t">Tong JL, Ashworth DR, Smith JE. Cardiovascular responses following laryngoscope assisted, fibreoptic orotracheal intubation. Anaesthesia 2005; 60:754.</a></li><li><a class="nounderline abstract_t">Moorthy SS, Greenspan CD, Dierdorf SF, Hillier SC. Increased cerebral and decreased femoral artery blood flow velocities during direct laryngoscopy and tracheal intubation. Anesth Analg 1994; 78:1144.</a></li><li><a class="nounderline abstract_t">Chraemmer-Jørgensen B, Høilund-Carlsen PF, Marving J, Christensen V. Lack of effect of intravenous lidocaine on hemodynamic responses to rapid sequence induction of general anesthesia: a double-blind controlled clinical trial. Anesth Analg 1986; 65:1037.</a></li><li><a class="nounderline abstract_t">Moulton C, Pennycook AG. Relation between Glasgow coma score and cough reflex. Lancet 1994; 343:1261.</a></li><li><a class="nounderline abstract_t">Chung KS, Sinatra RS, Halevy JD, et al. A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction. Can J Anaesth 1992; 39:774.</a></li><li><a class="nounderline abstract_t">Cork RC, Weiss JL, Hameroff SR, Bentley J. Fentanyl preloading for rapid-sequence induction of anesthesia. Anesth Analg 1984; 63:60.</a></li><li><a class="nounderline abstract_t">Dahlgren N, Messeter K. Treatment of stress response to laryngoscopy and intubation with fentanyl. Anaesthesia 1981; 36:1022.</a></li><li><a class="nounderline abstract_t">Splinter WM, Cervenko F. Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone. Can J Anaesth 1989; 36:370.</a></li><li><a class="nounderline abstract_t">Hussain AM, Sultan ST. Efficacy of fentanyl and esmolol in the prevention of haemodynamic response to laryngoscopy and endotracheal intubation. J Coll Physicians Surg Pak 2005; 15:454.</a></li><li><a class="nounderline abstract_t">Adachi YU, Satomoto M, Higuchi H, Watanabe K. Fentanyl attenuates the hemodynamic response to endotracheal intubation more than the response to laryngoscopy. Anesth Analg 2002; 95:233.</a></li><li><a class="nounderline abstract_t">del Río Vellosillo M, Gallego García J, Soliveres Ripoll J, et al. [Bolus administration of fentanyl vs continuous perfusion of remifentanil for control of hemodynamic response to laryngoscopy and orotracheal intubation: a randomized double-blind trial]. Rev Esp Anestesiol Reanim 2009; 56:287.</a></li><li><a class="nounderline abstract_t">Payne KA, Murray WB, Oosthuizen JH. Obtunding the sympathetic response to intubation. Experience at 2 minutes after administration of the test agent in patients with cerebral aneurysms. S Afr Med J 1988; 73:584.</a></li><li><a class="nounderline abstract_t">Robinson N, Clancy M. In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature. Emerg Med J 2001; 18:453.</a></li><li><a class="nounderline abstract_t">Butler J, Jackson R. Towards evidence based emergency medicine: best BETs from Manchester Royal Infirmary. Lignocaine premedication before rapid sequence induction in head injuries. Emerg Med J 2002; 19:554.</a></li><li><a class="nounderline abstract_t">Helfman SM, Gold MI, DeLisser EA, Herrington CA. Which drug prevents tachycardia and hypertension associated with tracheal intubation: lidocaine, fentanyl, or esmolol? Anesth Analg 1991; 72:482.</a></li><li><a class="nounderline abstract_t">Abou-Madi MN, Keszler H, Yacoub JM. Cardiovascular reactions to laryngoscopy and tracheal intubation following small and large intravenous doses of lidocaine. Can Anaesth Soc J 1977; 24:12.</a></li><li><a class="nounderline abstract_t">Bachofen M. [Suppression of blood pressure increases during intubation: lidocaine or fentanyl?]. Anaesthesist 1988; 37:156.</a></li><li><a class="nounderline abstract_t">Grover VK, Reddy GM, Kak VK, Singh S. Intracranial pressure changes with different doses of lignocaine under general anaesthesia. Neurol India 1999; 47:118.</a></li><li><a class="nounderline abstract_t">White PF, Schlobohm RM, Pitts LH, Lindauer JM. A randomized study of drugs for preventing increases in intracranial pressure during endotracheal suctioning. Anesthesiology 1982; 57:242.</a></li><li><a class="nounderline abstract_t">Donegan MF, Bedford RF. Intravenously administered lidocaine prevents intracranial hypertension during endotracheal suctioning. Anesthesiology 1980; 52:516.</a></li><li><a class="nounderline abstract_t">Bilotta F, Branca G, Lam A, et al. Endotracheal lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics in patients with severe head trauma. Neurocrit Care 2008; 8:241.</a></li><li><a class="nounderline abstract_t">Samaha T, Ravussin P, Claquin C, Ecoffey C. [Prevention of increase of blood pressure and intracranial pressure during endotracheal intubation in neurosurgery: esmolol versus lidocaine]. Ann Fr Anesth Reanim 1996; 15:36.</a></li><li><a class="nounderline abstract_t">Yano M, Nishiyama H, Yokota H, et al. Effect of lidocaine on ICP response to endotracheal suctioning. Anesthesiology 1986; 64:651.</a></li><li><a class="nounderline abstract_t">Raymondos K, Münte S, Krauss T, et al. Cortical activity assessed by Narcotrend in relation to haemodynamic responses to tracheal intubation at different stages of cortical suppression and reflex control. Eur J Anaesthesiol 2003; 20:44.</a></li><li><a class="nounderline abstract_t">Oda Y, Nishikawa K, Hase I, Asada A. The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia. Anesth Analg 2005; 100:733.</a></li><li><a class="nounderline abstract_t">Feng CK, Chan KH, Liu KN, et al. A comparison of lidocaine, fentanyl, and esmolol for attenuation of cardiovascular response to laryngoscopy and tracheal intubation. Acta Anaesthesiol Sin 1996; 34:61.</a></li><li><a class="nounderline abstract_t">Clancy M, Halford S, Walls R, Murphy M. In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? A literature review. Emerg Med J 2001; 18:373.</a></li><li><a class="nounderline abstract_t">Moss E, Powell D, Gibson RM, McDowall DG. Effect of etomidate on intracranial pressure and cerebral perfusion pressure. Br J Anaesth 1979; 51:347.</a></li><li><a class="nounderline abstract_t">Modica PA, Tempelhoff R. Intracranial pressure during induction of anaesthesia and tracheal intubation with etomidate-induced EEG burst suppression. Can J Anaesth 1992; 39:236.</a></li><li><a class="nounderline abstract_t">Chesnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma 1993; 34:216.</a></li><li><a class="nounderline abstract_t">May N, Anderson K. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: Suxamethonium (succinylcholine) for RSI and intubation in head injury. Emerg Med J 2012; 29:511.</a></li><li><a class="nounderline abstract_t">Lanier WL, Iaizzo PA, Milde JH. Cerebral function and muscle afferent activity following intravenous succinylcholine in dogs anesthetized with halothane: the effects of pretreatment with a defasciculating dose of pancuronium. Anesthesiology 1989; 71:87.</a></li><li><a class="nounderline abstract_t">Cottrell JE, Hartung J, Giffin JP, Shwiry B. Intracranial and hemodynamic changes after succinylcholine administration in cats. Anesth Analg 1983; 62:1006.</a></li><li><a class="nounderline abstract_t">Kovarik WD, Mayberg TS, Lam AM, et al. Succinylcholine does not change intracranial pressure, cerebral blood flow velocity, or the electroencephalogram in patients with neurologic injury. Anesth Analg 1994; 78:469.</a></li><li><a class="nounderline abstract_t">Sun HL, Wu TJ, Ng CC, et al. Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation. J Clin Anesth 2009; 21:103.</a></li><li><a class="nounderline abstract_t">Warner KJ, Cuschieri J, Copass MK, et al. The impact of prehospital ventilation on outcome after severe traumatic brain injury. J Trauma 2007; 62:1330.</a></li><li><a class="nounderline abstract_t">Carney N, Totten AM, O'Reilly C, et al. Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition. Neurosurgery 2017; 80:6.</a></li></ol></div><div id="topicVersionRevision">Topic 266 Version 24.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23511147" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The relationship between head injury severity and hemodynamic response to tracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23599399" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Tactile stimulation of the oropharynx elicits sympathoexcitation in conscious humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16211744" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Which is responsible for the haemodynamic response due to laryngoscopy and endotracheal intubation? Catecholamines, vasopressin or angiotensin?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12145076" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Hemodynamic responses to tracheal intubation with laryngoscope versus lightwand intubating device (Trachlight) in adults with normal airway.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3828177" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Cardiovascular and catecholamine responses to laryngoscopy with and without tracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/900548" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Circulatory changes during direct laryngoscopy and tracheal intubation: influence of duration of laryngoscopy with or without prior lidocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16388166" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Opioid sparing during endotracheal intubation using McCoy laryngoscope in neurosurgical patients: the comparison of haemodynamic changes with Macintosh blade in a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12719053" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Hemodynamic and catecholamine response to tracheal intubation: direct laryngoscopy compared with fiberoptic intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16029223" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Cardiovascular responses following laryngoscope assisted, fibreoptic orotracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8198273" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Increased cerebral and decreased femoral artery blood flow velocities during direct laryngoscopy and tracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3530049" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Lack of effect of intravenous lidocaine on hemodynamic responses to rapid sequence induction of general anesthesia: a double-blind controlled clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7910279" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Relation between Glasgow coma score and cough reflex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1363221" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : A comparison of fentanyl, esmolol, and their combination for blunting the haemodynamic responses during rapid-sequence induction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6318605" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Fentanyl preloading for rapid-sequence induction of anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7032347" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Treatment of stress response to laryngoscopy and intubation with fentanyl.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2758537" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Haemodynamic responses to laryngoscopy and tracheal intubation in geriatric patients: effects of fentanyl, lidocaine and thiopentone.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16202353" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Efficacy of fentanyl and esmolol in the prevention of haemodynamic response to laryngoscopy and endotracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12088976" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Fentanyl attenuates the hemodynamic response to endotracheal intubation more than the response to laryngoscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19580131" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : [Bolus administration of fentanyl vs continuous perfusion of remifentanil for control of hemodynamic response to laryngoscopy and orotracheal intubation: a randomized double-blind trial].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3131884" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Obtunding the sympathetic response to intubation. Experience at 2 minutes after administration of the test agent in patients with cerebral aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11696494" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : In patients with head injury undergoing rapid sequence intubation, does pretreatment with intravenous lignocaine/lidocaine lead to an improved neurological outcome? A review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12421789" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Towards evidence based emergency medicine: best BETs from Manchester Royal Infirmary. Lignocaine premedication before rapid sequence induction in head injuries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1672488" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Which drug prevents tachycardia and hypertension associated with tracheal intubation: lidocaine, fentanyl, or esmolol?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/832175" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Cardiovascular reactions to laryngoscopy and tracheal intubation following small and large intravenous doses of lidocaine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3381993" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : [Suppression of blood pressure increases during intubation: lidocaine or fentanyl?].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10402336" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Intracranial pressure changes with different doses of lignocaine under general anaesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7114549" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : A randomized study of drugs for preventing increases in intracranial pressure during endotracheal suctioning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7377599" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Intravenously administered lidocaine prevents intracranial hypertension during endotracheal suctioning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17928962" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Endotracheal lidocaine in preventing endotracheal suctioning-induced changes in cerebral hemodynamics in patients with severe head trauma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8729308" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : [Prevention of increase of blood pressure and intracranial pressure during endotracheal intubation in neurosurgery: esmolol versus lidocaine].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3963485" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Effect of lidocaine on ICP response to endotracheal suctioning.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12553387" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Cortical activity assessed by Narcotrend in relation to haemodynamic responses to tracheal intubation at different stages of cortical suppression and reflex control.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15728061" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : The short-acting beta1-adrenoceptor antagonists esmolol and landiolol suppress the bispectral index response to tracheal intubation during sevoflurane anesthesia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9084524" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : A comparison of lidocaine, fentanyl, and esmolol for attenuation of cardiovascular response to laryngoscopy and tracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11559609" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : In patients with head injuries who undergo rapid sequence intubation using succinylcholine, does pretreatment with a competitive neuromuscular blocking agent improve outcome? A literature review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/465257" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Effect of etomidate on intracranial pressure and cerebral perfusion pressure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1551154" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Intracranial pressure during induction of anaesthesia and tracheal intubation with etomidate-induced EEG burst suppression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8459458" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The role of secondary brain injury in determining outcome from severe head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22635391" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 3: Suxamethonium (succinylcholine) for RSI and intubation in head injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2751145" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Cerebral function and muscle afferent activity following intravenous succinylcholine in dogs anesthetized with halothane: the effects of pretreatment with a defasciculating dose of pancuronium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6625204" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Intracranial and hemodynamic changes after succinylcholine administration in cats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8109761" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Succinylcholine does not change intracranial pressure, cerebral blood flow velocity, or the electroencephalogram in patients with neurologic injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19329013" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Efficacy of oropharyngeal lidocaine instillation on hemodynamic responses to orotracheal intubation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17563643" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The impact of prehospital ventilation on outcome after severe traumatic brain injury.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27654000" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Guidelines for the Management of Severe Traumatic Brain Injury, Fourth Edition.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
